View clinical trials related to HPV Infections.
Filter by:HPV infection has been recognized as the most prevalent sexual transmitted infection worldwide. Burden of many HPV related diseases is well known particularly regarding the different associated cancers (cervical, anal, vaginal, vulvar, oro-pharyngeal) (3) ; however, there is much less available information on the general burden of genital warts, the associated HPV types, the costs of related medical treatments and the knowledge and perceptions towards the disease and its prevention. Objectives: 1. To determine the HPV genotypes distribution in genital warts in the study population. 2. To assess the knowledge about transmission & prevention of HPV infection related diseases 3. To determine the direct medical costs of genital warts attention.
A study to test the safety and effectiveness of Quadrivalent HPV (types 6, 11, 16, 18) L1 VLP vaccine against combined incidence of HPV 6/11/16/18-related persistent infection and vaccine type-specific genital disease among Chinese females between the ages of 20 and 45.
This study is designed to determine the tolerability and immunogenicity of a 3-dose regimen of Gardasil administered to healthy married females between 16 and 23 years of age, in India.
This is a research study looking at gene characteristics in blood and Pap smear samples in hopes of identifying markers that will predict if the HPV infection is present or not.
The aim of this study is to evaluate the significance of an elevated high-risk HPV (HR-HPV) viral load.
To prove that quadrivalent HPV (types 6, 11, 16, 18) L1 virus-like particle (VLP) vaccine is generally safe and well tolerated in the Chinese population.
The study evaluates the immunogenicity, safety and tolerability of V501 in preadolescent females
A study to evaluate the efficacy, immunogenicity, safety and tolerability of V501 in adult women